Related by context. All words. (Click for frequent words.) 69 MAGE A3 ASCI 69 Nexavar sorafenib 69 Zarnestra 69 Pirfenidone 69 Somatuline Depot 69 Torisel temsirolimus 69 acyclovir Lauriad R 68 multiple myeloma MM 68 Velcade bortezomib 68 Ixempra 68 refractory chronic lymphocytic 68 Sutent sunitinib 68 Rituxan rituximab 68 rasagiline tablets 68 radioimmunotherapeutic agent 68 Raptiva ® 68 Arzerra TM 68 Temsirolimus 68 Gleevec Glivec 68 RANK Ligand inhibitor 68 Certican 68 Amrubicin 68 RhuDex ® 67 Raptiva R 67 Humira adalimumab 67 PF # [002] 67 Alvesco R 67 Sprycel dasatinib 67 Alemtuzumab 67 Plenaxis TM 67 orphan medicinal product 67 Ceflatonin 67 ACOMPLIA R 67 adalimumab Humira 67 Dacogen injection 67 TEMODAL 66 Marketing Authorisation Application MAA 66 PROVENGE ® 66 Arranon 66 Aflibercept 66 Jevtana 66 Alimta pemetrexed 66 Soliris TM eculizumab 66 lumiliximab 66 Bayer Nexavar 66 Peginterferon alfa 2b 66 refractory APL 66 etanercept Enbrel 66 autologous cellular immunotherapy 66 Liprotamase 66 thetreatment 66 Phase Ib IIa 66 PrevOnco 66 Phase IIIb clinical 66 Sebivo 66 Cloretazine ® 66 UCB Cimzia 66 YONDELIS 66 Vitrasert R 66 Tasigna nilotinib 66 Troxatyl TM 66 Vandetanib 66 Onco TCS 66 abatacept Orencia 66 Votrient 66 initiated Phase Ib 66 RhuDex 66 CIMZIA r 66 Cimzia certolizumab pegol 66 SNT MC# 66 refractory acute promyelocytic 66 Orphan Status 66 INSPIRE Trial Phase III 66 Certolizumab pegol 66 Noxafil 65 Granted Orphan Drug 65 NerPharMa 65 Firazyr 65 Arzerra 65 interferon gamma 1b 65 Evoltra ® 65 Temodar ® 65 UPLYSO 65 midstage clinical 65 Erbitux cetuximab 65 Zytiga 65 orphan designation 65 SYCREST 65 Nabi HB Intravenous 65 Gleevec imatinib mesylate 65 pregabalin Lyrica 65 Allovectin 7 65 ZACTIMA 65 Romiplostim 65 SinuNase ™ 65 Vidaza azacitidine 65 AVASTIN 65 reslizumab 65 Tykerb lapatinib 65 trastuzumab DM1 65 Tarceva TM 65 Phase III TRIST 65 Taxotere docetaxel 65 Cladribine 65 omacetaxine mepesuccinate 65 relapsed indolent NHL 65 Plenaxis R 65 Vectibix panitumumab 65 Torisel 65 ixabepilone 65 Thalidomide Pharmion 65 Advagraf 65 Vimpat ® lacosamide 65 Troxatyl 65 Removab 65 Teysuno 65 phase III isavuconazole 65 RAPTIVA 65 vinflunine 65 mitogen activated ERK kinase 65 BCR ABL inhibitor 65 SNT-MC#/idebenone 65 liver resection surgeries 65 sunitinib Sutent 65 Actimmune ® 65 LymphoStat B TM 65 refractory acute myeloid 65 Fast Track Status 65 lorvotuzumab mertansine 65 Somatuline R Autogel R 65 LymphoStat B belimumab 65 thalidomide Thalomid 65 BrachySil TM 65 Neupro R 64 herpetic keratitis 64 IMA# 64 miconazole Lauriad 64 Risperidone Oral Solution 64 SPRYCEL ® 64 SUTENT ® 64 Neupogen ® 64 gepirone ER 64 Irinotecan 64 relapsed leukemia 64 Campath alemtuzumab 64 Xyrem ® 64 eprodisate Fibrillex TM 64 Treanda bendamustine 64 Oxaliplatin 64 oral methylnaltrexone 64 Pemetrexed 64 GW# [003] 64 ZOLINZA 64 relapsed MM 64 novel oral anticoagulant 64 AstraZeneca Iressa 64 Urocidin 64 SinuNase TM 64 Daclizumab 64 Pfizer Sutent 64 PrevOnco ™ 64 Omapro 64 Orphan Designation 64 Tanespimycin 64 RSR# 64 Valtropin 64 RhuDex R 64 Kepivance 64 Merck KGaA Erbitux 64 Phase IIb clinical trials 64 receptor tyrosine kinase inhibitor 64 recurrent glioblastoma multiforme 64 guanfacine extended release 64 ONCASPAR 64 Dendreon Provenge 64 Application MAA 64 tafamidis 64 Zemplar Capsules 64 Zenpep 64 Marketing Authorisation Application 64 VALSTAR 64 Abilify aripiprazole 64 Pirespa 64 Orphan Drug status 64 IL# PE#QQR 64 chronic idiopathic thrombocytopenic purpura 64 metastatic hormone refractory 64 OvaRex ® MAb 64 BioNumerik 64 dose escalation clinical 64 Chronic Lymphocytic Leukemia CLL 64 Benlysta belimumab 64 Nexavar ® 64 Gamunex C 64 ORENCIA R 64 Uplyso 64 Anidulafungin 64 MOVIPREP R 64 Gleevec imatinib 64 Clofarabine 64 Femara letrozole 64 Pertuzumab 64 myelodysplastic myeloproliferative diseases 64 Everolimus 64 FOLOTYN ® 64 Lambert Eaton Myasthenic 64 relapsed refractory aggressive 64 phase IIb clinical 64 CHOP chemotherapy 64 rALLy clinical trial 64 Eloxatin ® 64 ZEVALIN ® 64 severe hypercholesterolemia 64 HCl capsules 64 Genentech Rituxan 64 Revlimid lenalidomide 64 Abstral 64 Aryplase 64 Onrigin 64 AMITIZA R 64 rufinamide 64 everolimus tablets 64 HuMax CD4 64 Hycamtin 64 albiglutide 64 LEUKINE 64 Iressa gefitinib 63 multicenter Phase II 63 OncoVex 63 Zavesca R 63 relapsing remitting MS RRMS 63 exocrine pancreatic insufficiency EPI 63 Ceflatonin R 63 ONGLYZA ™ 63 Evoltra TM 63 RoActemra 63 AAG geldanamycin analog 63 Degarelix 63 novel histone deacetylase 63 Provenge prostate cancer 63 Raptiva efalizumab 63 Cloretazine 63 Dementia Related Psychosis 63 Omnitarg 63 histone deacetylase HDAC inhibitor 63 Tramiprosate ALZHEMED TM 63 GTC recombinant form 63 Actemra tocilizumab 63 humanised monoclonal antibody 63 efalizumab 63 refractory myeloma 63 balsalazide tablet 63 Phase #b/#a clinical 63 StemEx R 63 Rebif ® 63 Cipralex ® 63 Increlex TM 63 GTC recombinant human 63 Rilutek 63 Febuxostat 63 seliciclib CYC# 63 TORISEL TM 63 Hodgkin lymphoma HL 63 Targretin capsules 63 TASKi3 63 Rhucin R 63 Serdolect ® 63 Canvaxin 63 SIR Spheres 63 Dalbavancin 63 Arimidex anastrozole 63 CLARITY study 63 Friedreich Ataxia FRDA 63 tramiprosate ALZHEMED TM 63 R sorafenib tablets 63 Genasense ® 63 PD LID 63 forodesine 63 refractory Hodgkin lymphoma 63 metastatic renal cell 63 Avastin bevacizumab 63 MabThera Rituxan 63 Annamycin 63 romiplostim 63 Simponi golimumab 63 Mirapexin 63 alemtuzumab Campath 63 OMAPRO ™ 63 Pazopanib 63 Panzem R 63 Plenaxis 63 cell lymphoma CTCL 63 Neulasta R 63 Onconase 63 R bendamustine hydrochloride 63 Silodosin 63 Kiacta 63 CONBRIZA 63 Orphan Drug designation 63 Cimzia TM 63 Increlex R 63 Fodosine 63 depressive episodes associated 63 EGS# 63 Glivec imatinib 63 cetuximab Erbitux 63 fostamatinib 63 Roche Actemra 63 Initiates Enrollment 63 mitoxantrone plus 63 BRILINTA 63 ZEFTERA TM Zevtera TM 63 Aceon 63 Archexin 63 Neuvenge 63 mertansine 63 Basilea Toctino R 63 dasatinib Sprycel ® 63 generation purine nucleoside 63 IgG1 monoclonal antibody 63 Fludara ® 63 Personalized Immunotherapy 63 Sanvar R 63 Ziprasidone 63 KRN# 63 ofatumumab HuMax CD# 63 phase IIb trial 63 Navelbine ® 63 R sipuleucel T 63 Aptivus ® 63 OSI Tarceva 63 Somatuline Autogel 63 patients receiving myelosuppressive 63 antibody MAb 63 Saforis 63 Pivotal Phase III 63 hoFH 63 Aplidin 63 Monoclonal antibody 63 eribulin mesylate 63 Yondelis ® 63 Ocrelizumab 63 Roche Xeloda 63 Ceplene ® histamine dihydrochloride 63 Biologic License Application BLA 63 refractory colorectal cancer 63 Zavesca r 63 beta 1a 63 investigational oral hepatitis C 63 cutaneous T 63 Emezine 63 Preotact R 63 MabCampath 63 Tocosol Paclitaxel 63 rhIGF-I/rhIGFBP-3 63 acetonide FA 63 Cancidas 63 GATTEX TM 62 cathepsin K inhibitor 62 Sanofi Aventis Taxotere 62 Phase IIIb study 62 pioglitazone hydrochloride 62 Combination REOLYSIN R 62 Promacta 62 Mepact 62 lymphoid malignancies 62 vapreotide acetate 62 EOquin TM 62 progressive metastatic prostate 62 rilonacept 62 Zemplar 62 Somatuline R Depot 62 Adjuvant Treatment 62 Egrifta 62 oral ridaforolimus 62 Zenapax 62 miconazole Lauriad R 62 Arcalyst 62 Pulminiq 62 Myelodysplastic Syndrome MDS 62 PLAVIX ® 62 subcutaneous methylnaltrexone 62 Hedgehog Pathway Inhibitor 62 sunitinib malate 62 relapsing multiple sclerosis 62 Eribulin 62 aurora kinase 62 PANVAC VF 62 Novartis Afinitor 62 metastatic malignant 62 Azacitidine 62 biologic therapy 62 Cerepro ® 62 VIVITROL ® 62 Eli Lilly Cymbalta 62 microtubule inhibitor 62 sorafenib Nexavar 62 Alzhemed TM 62 Herceptin trastuzumab 62 Orphan designation 62 Tamsulosin 62 LSE ASM 62 Cimzia ® certolizumab pegol 62 Manja Bouman CEO 62 Initiate Clinical Trial 62 IIa trial 62 RoACTEMRA 62 THALOMID 62 Intravenous CP 62 E1 INT TM 62 alkylating agent 62 refractory indolent non 62 drug Treanda 62 developer Antisoma plc 62 Bendamustine 62 targeted antifolate 62 Renal Cell Carcinoma RCC 62 pediatric Crohn disease 62 TAXUS Element Stent System 62 CAMPATH 62 dalbavancin 62 miconazole Lauriad ® 62 pediatric acute lymphoblastic 62 TM pralatrexate injection 62 histamine dihydrochloride 62 Vertex hepatitis C 62 Fluconazole 62 recurrent GBM 62 intravenous iclaprim 62 Onalta ™ 62 MGd 62 Qutenza TM 62 Initiates Phase III 62 rheumatoid arthritis psoriatic arthritis 62 Orencia abatacept 62 Muraglitazar 62 Angiox ® 62 inhaled AAT 62 methylnaltrexone bromide 62 Plicera 62 Completes Patient Enrollment 62 cytokine refractory 62 RhuDex TM 62 Sycrest 62 Phase III randomized controlled 62 MIS# 62 IRESSA 62 glatiramer 62 lintuzumab SGN 62 biliary tract cancer 62 CIP Fenofibrate 62 Sutent sunitinib malate 62 Esbriet ® 62 indolent NHL 62 Myocet 62 Fabry Disease 62 midstage trials 62 Alvesco ® 62 Application BLA 62 phase IIb III 62 alefacept 62 CIP TRAMADOL ER 62 supplemental biologics 62 Hexvix ® 62 Soliris eculizumab 62 PI3K/Akt pathway inhibitor 62 OMP designation 62 Roche Herceptin 62 FTY# fingolimod 62 Cellegesic 62 IV Busulfex 62 Clolar ® 62 Gleevec resistant 62 Ambrisentan 62 Quinamed 62 Treanda 62 Telavancin 62 anthracycline taxane 62 DIFICID ™ 62 REMINYL ® 62 Dacogen decitabine 62 erlotinib Tarceva 62 adult chronic ITP 62 Receives Orphan Drug Designation 62 Esbriet pirfenidone 62 Romidepsin 62 sNDA filing 62 Nivestim 62 Mycophenolate Mofetil 62 oxypurinol 62 STEDESA 62 Imatinib Mesylate 62 Dabigatran etexilate 62 huN# DM1 62 Cintredekin besudotox 62 follicular Non Hodgkin 62 Initiate Phase 62 refractory CLL 62 Glybera R 62 ThermoDox R 62 Antisoma AS# 62 PEG interferon 62 Tysabri natalizumab 62 Proquin XR 62 Aurograb 62 ORENCIA ® 62 Maraviroc 62 Xelox 62 Epratuzumab 62 Flutiform ™ 62 advanced metastatic renal 62 sorafenib tablets 62 Natalizumab 62 Fingolimod 62 granted Ortec 62 CLL SLL 62 Bosutinib 62 lenalidomide Revlimid R 62 markets HP Acthar 62 Baraclude entecavir 62 CIMZIA TM 62 Lenalidomide 62 donepezil hydrochloride 62 opioid induced constipation OIC 62 Modrenal R 62 vinorelbine tartrate 62 Ceplene histamine dihydrochloride 62 Trobalt 62 radiotherapeutic 62 Files Investigational 62 single injection viscosupplement 62 Adrenomyeloneuropathy AMN 62 Tarceva erlotinib 62 octreotide acetate 62 Entocort 62 Act PDUFA date 62 TBC# 62 BEXXAR 62 Civacir 62 malignant ascites 62 evaluating REVLIMID 62 enoxaparin sodium injection 62 Centralized Procedure 61 docetaxel Taxotere ® 61 Vertex telaprevir 61 Calcium Acetate 61 oral rivaroxaban 61 pain palliation 61 Ofatumumab 61 epoetin zeta 61 Zenvia ™ 61 mesylate 61 Iluvien ® 61 Tegaserod 61 Severe Sepsis 61 Levoleucovorin 61 velaglucerase alfa 61 Specifid 61 gemcitabine Gemzar ® 61 hematological malignancy 61 Novartis Gleevec 61 intravenous AAT 61 SUPPRELIN R LA 61 relapsed multiple myeloma 61 Files IND 61 gastrointestinal stromal tumors GIST 61 formerly LymphoStat B 61 EGFR expressing mCRC 61 Safinamide 61 Zavesca 61 Bevacizumab Avastin 61 motesanib diphosphate 61 Gemcitabine 61 targeted radiotherapeutic 61 pharmacokinetic PK study 61 severe gastroparesis 61 Clevudine 61 Halaven 61 drug belatacept 61 pancreatic enzyme replacement 61 sitaxsentan 61 Pixuvri 61 mRCC 61 non resectable 61 sNDAs 61 cinacalcet HCl 61 ELACYT 61 Idiopathic Pulmonary Fibrosis 61 methylnaltrexone 61 Remicade infliximab 61 icatibant 61 Sudhir Agrawal D.Phil 61 relapsed refractory multiple myeloma 61 Proellex TM 61 Onglyza saxagliptin 61 Yervoy 61 acyclovir Lauriad ® 61 ISO Vorin TM 61 brivaracetam 61 NOXAFIL 61 Xibrom TM 61 Orathecin 61 trastuzumab DM1 T DM1 61 galiximab 61 oxymorphone ER 61 Omacetaxine 61 Tesmilifene 61 acute HAE attacks 61 Hsp# Inhibitor 61 BCIRG 61 anticancer compound 61 gastrointestinal stromal tumor GIST 61 gets USFDA nod 61 Argatroban 61 trabectedin 61 Fast Track designations 61 afamelanotide 61 Evoltra 61 Rapinyl 61 Trovax 61 Cx# [002] 61 PSMA ADC 61 CA9 SCAN 61 Camptosar ® 61 highly purified pasteurized 61 relapsed CLL 61 Clinical Trial Investigating REOLYSIN 61 paclitaxel Taxol R 61 radiation sensitizer 61 Glatiramer Acetate 61 anagrelide 61 EndoTAG TM -1 61 Campath ® 61 CRMD# 61 Abiraterone acetate 61 Multiple Ascending Dose 61 CIMZIA TM certolizumab pegol 61 gefitinib Iressa 61 Ganciclovir 61 tocilizumab 61 Zidovudine Tablets 61 OHR/AVR# 61 brivanib 61 REBETOL combination 61 ezogabine 61 sublingual tablets 61 Kamada AAT 61 Neulasta ® 61 ISENTRESS raltegravir 61 Xeloda ® 61 Exalgo TM 61 phase Ib 61 Frova ® 61 Tracleer ® bosentan 61 Roflumilast 61 Abstral ® 61 Simulect 61 Brentuximab Vedotin SGN 61 dirucotide MBP# 61 ALGRX 61 YONDELIS R 61 Sanctura XR 61 Alkeran 61 novel emulsion formulation 61 oral immunomodulatory 61 TRISENOX 61 Polyphenon ® E 61 Tocilizumab 61 ARIXTRA R 61 Deferiprone 61 Decitabine 61 Panzem R NCD 61 COLAZAL R 61 including eniluracil ADH 61 Prosaptide 61 Vidaza R 61 PDUFA Prescription Drug 61 Medicinal Products EMEA 61 relapsed MCL 61 BENLYSTA TM 61 Retacrit 61 oral salmon calcitonin 61 mesylate tablets approved 61 Afatinib 61 docetaxel Taxotere R 61 evaluating tivozanib 61 evaluating satraplatin 61 Etanercept 61 Myozyme alglucosidase alfa 61 TheraCIM 61 VitiGam 61 PNP inhibitor 61 briakinumab 61 Meets Primary Endpoint 61 Prednisone Against Refractory 61 Loramyc TM 61 somatostatin analog 61 Fibrillex TM 61 ILUVIEN ® 61 Velaglucerase Alfa 61 esophageal candidiasis 61 PRIALT 61 Vascular Wrap TM 61 MyVax R 61 Prestara 61 Golimumab 61 Aviptadil 61 INTEGRILIN R eptifibatide Injection 61 Hematological Malignancies 61 Virulizin 61 tacrolimus capsules 61 Phase Ib clinical 61 Gemzar gemcitabine 61 proteasome inhibitor 61 alvimopan 61 arsenic trioxide injection 61 personalized cellular immunotherapy 61 subcutaneous formulation 61 eritoran 61 DEB# 61 Riluzole 61 miconazole MBT 61 assigned PDUFA 61 Tramadol ER 61 BYETTA ® 61 MAA submission 61 Icatibant 61 Brilique 61 AZD# TC 61 diabetic neuropathic pain 61 refractory metastatic colorectal cancer 61 PNT# 61 HERCEPTIN 61 Phase Ib II 61 dextromethorphan quinidine 61 Mycamine 61 dasatinib Sprycel 61 BENLYSTA ® 61 Diamyd ® 61 Auxilium Pharma 61 TransMID 61 vemurafenib 61 IV acetaminophen 61 Novantrone 61 TORISEL 61 Bonefos 61 R abatacept 61 Arimoclomol 61 OvaRex R 61 CytoFabTM 61 pseudobulbar affect PBA 61 Paraplatin 61 vandetanib 61 telomerase therapeutic 61 Phase III multicenter 61 CytoFab 61 Loramyc ™ 61 photoprotective drug 61 Fenoglide 61 Luveris 61 CD# antibody [002] 61 Adentri 61 assessing T DM1 61 Interferon beta 1b 61 Nexavar tablets 61 ZALBIN 61 imatinib Gleevec ® 61 Fludara 61 FDA Approvable Letter 61 ELIQUIS 61 GlaxoSmithKline Tykerb 61 phase IIa clinical 61 Stedesa 61 vidofludimus 61 Receives Fast Track 61 rituximab Rituxan 61 QNEXA ® 61 RTP #i 61 Release Capsules 61 BLA filing 61 Zelnorm Zelmac 61 riociguat 61 previously untreated follicular 61 Loramyc R 61 leukemia AML 61 Evoltra R 61 oral deforolimus 61 investigational humanized monoclonal antibody 61 tubulin inhibitor 61 ATryn ® 61 Orphan Drug designations 61 Entecavir 61 Cabazitaxel 61 Ilaris ® 61 ONTAK 61 taxane refractory 61 nasal calcitonin product 61 Hexvix 61 huC# DM4 61 FROVA 61 Octreolin 61 atypical antipsychotic medication 61 Erlotinib 61 HepaGam B 61 lucinactant 61 Gemzar ® 60 Milnacipran 60 BARACLUDE ® 60 Afinitor everolimus 60 Zortress 60 MYLOTARG 60 Epirubicin 60 ® bortezomib 60 Albugon 60 Kevetrin ™ 60 Gefitinib 60 refractory cutaneous T 60 Pegintron 60 Bayer Onyx 60 selective modulator 60 STRIDE PD 60 eltrombopag 60 baminercept 60 Anti VEGF 60 chimeric monoclonal antibody 60 randomized controlled Phase 60 zanolimumab 60 FACTIVE R gemifloxacin 60 FOR FURTHER INFORMATION ABOUT 60 IMiDs R 60 Submits NDA 60 BLP# Liposome Vaccine 60 Toctino R 60 Angiox R 60 Subpart E 60 Kynapid 60 JAK inhibitor 60 prucalopride 60 Drug Eluting Stent System 60 DCVax Brain 60 tolevamer 60 Amlodipine Besylate 60 FIRAZYR 60 cetuximab Erbitux R 60 Afinitor ® 60 vaccine Synflorix 60 Fx #A 60 Rituximab 60 subcutaneously administered 60 PROMACTA 60 KNS # 60 OMP #R# 60 Theratope 60 MIVI III 60 Genzyme Myozyme 60 Rebif interferon beta 1a 60 Ixabepilone 60 Instanyl 60 Pruvel 60 pegylated interferon alpha 60 investigational therapies 60 apaziquone 60 Product Monograph 60 humanized interleukin 6 60 BRIM3 60 IIb clinical trial 60 Taxotere ® 60 MKC# MT 60 citalopram hydrobromide 60 Pyridorin 60 bortezomib Velcade R 60 Belimumab 60 Fosrenol 60 chemotherapy fludarabine 60 nilotinib Tasigna 60 achieved CCyR 60 sargramostim 60 anti angiogenic therapy 60 TRX1 60 PDX pralatrexate 60 acute mania 60 Begins Dosing 60 multicenter Phase 60 samalizumab 60 metastatic colorectal carcinoma 60 TREANDA 60 Syndrome LEMS 60 Vitaxin 60 developing Zerenex ferric 60 Eprodisate KIACTA TM 60 polycythemia vera essential thrombocythemia 60 THALOMID R 60 Tocosol 60 Triapine R 60 Revolade 60 Bayer HealthCare Onyx Pharmaceuticals 60 APPRAISE 60 EVIZON TM 60 clofarabine 60 Orazol 60 kidney urologic 60 oral dual endothelin 60 docetaxel Injection Concentrate 60 Tiuxetan 60 Factor VIIa 60 buccal spray 60 FDA Accepts 60 HP Acthar Gel repository 60 Paliperidone Palmitate 60 Rasagiline 60 AERIUS 60 FDA Oncologic Drugs 60 ANTEGREN 60 aripiprazole Abilify 60 immunotherapeutic agent 60 CHAMPION PCI 60 Marketing Authorization Applications 60 Expedited Review 60 prokinetic agent 60 Vernakalant 60 Keppra ® XR 60 Taxol paclitaxel 60 Movectro 60 Temodal 60 Zolinza 60 Serdolect 60 oxaliplatin Eloxatin 60 Fortigel 60 Cariprazine 60 oropharyngeal candidiasis OPC 60 TYGACIL 60 JOULFERON 60 Victoza liraglutide 60 CDP# 60 reduce serum phosphate 60 apricitabine ATC 60 Zalypsis 60 novel therapeutic antibodies 60 Onbrez Breezhaler 60 CALGB # [002] 60 adenosine injection 60 Proleukin 60 Pegloticase 60 desvenlafaxine 60 granted orphan medicinal 60 Folotyn 60 Proxinium TM 60 Extavia 60 Aztreonam 60 immunotherapeutic vaccine 60 Xolegel 60 vismodegib 60 Elesclomol 60 FIRMAGON R 60 REBETOL combination therapy 60 Eligard ® 60 approved incretin mimetic 60 TYZEKA 60 Tyzeka Sebivo 60 VNP#M 60 AA amyloidosis 60 Eculizumab 60 IMiDs ® 60 SAR# [004] 60 Vernalis plc 60 Firdapse 60 quetiapine fumarate 60 Japanese Encephalitis vaccine 60 vosaroxin 60 paclitaxel poliglumex 60 BCG refractory 60 Trelstar R 60 Zirgan 60 BCR ABL inhibitors 60 Alitretinoin 60 Cutaneous T 60 phase IIa 60 Fusilev 60 darbepoetin alfa Aranesp 60 demonstrated antitumor activity 60 Zorbtive TM 60 OVATURE 60 reversing heparin 60 cardio renal 60 Ozurdex 60 CAELYX 60 SNS# T 60 Lubiprostone 60 LHRH antagonist 60 Ganite ® 60 bosutinib 60 bortezomib Velcade 60 Tracleer r 60 HuMax TAC 60 Bazedoxifene 60 treatment naive genotype 60 generation PNP inhibitor 60 Synvisc ONE 60 Teriparatide